An automated MAS derivatives reporting solution delivered through
MAP FinTech, Complyport’s award-winning RegTech platform.
Relevant Regulation: Securities and Futures (Reporting of Derivatives Contracts) Regulations 2013
Start Date: 31 October 2013
Types of firms affected: Singapore counterparties to a derivative contract such as banks, finance companies, capital markets services, significant derivative holders and others.
Supervisory authority: MAS
Frequency of reporting: T+2
Our MAS Reporting Service, delivered through MAP FinTech, Complyport’s award-winning RegTech platform, maps all compulsory trade data to the format required by the relevant Trade Repository under the Monetary Authority of Singapore’s Reporting of Derivatives Contracts regime.
The service ensures that reporting templates remain aligned with regulatory obligations throughout the engagement period, including updates arising from changes to MAS rules. With the MAS Rewrite in effect since 21 October 2024, the service helps firms comply with the new reporting standards, including the mandatory use of ISO 20022 XML, enhanced data requirements, T+2 submission timelines and event-driven reporting logic.
Our UPI Link Service, delivered through MAP FinTech, Complyport’s award-winning RegTech platform, helps companies accurately match their products’ attributes with Unique Product Identifiers already issued in the ANNA-DSB database. This helps reporting firms identify and use the correct UPI code in their transaction reporting.
With the sweeping changes introduced by the MAS Rewrite, your firm needs a partner that can provide stability, expertise, and adaptability. Trust Complyport to ensure accurate, timely, and transparent reporting—keeping you compliant and confident in a demanding regulatory environment.
Manage your EMIR reporting through MAP FinTech, Complyport’s award-winning RegTech Platform. The platform supports the reporting lifecycle within one centralised environment, helping firms improve data quality, automate processes and maintain greater oversight of their regulatory obligations.